Next Article in Journal
Preparation and Characterization of Microemulsions Based on Antarctic Krill Oil
Previous Article in Journal
Antioxidant Peptides from Sepia esculenta Hydrolyzate Attenuate Oxidative Stress and Fat Accumulation in Caenorhabditis elegans
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dactylospenes A–E, Sesterterpenes from the Marine Sponge Dactylospongia elegans

1
Department of Marine Biomedicine and Polar Medicine, Naval Medical Center of PLA, Second Military Medical University, Shanghai 200433, China
2
Research Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
3
Department of Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama, Kanagawa 223-8522, Japan
4
Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Second Military Medical University, Shanghai 200433, China
5
Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, CA 92093, USA
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2020, 18(10), 491; https://doi.org/10.3390/md18100491
Submission received: 29 August 2020 / Revised: 22 September 2020 / Accepted: 22 September 2020 / Published: 25 September 2020

Abstract

:
Chemical investigation on a marine sponge, Dactylospongia elegans, yielded five new γ-oxygenated butenolide sesterterpene derivatives, dactylospenes A–E (15), as well as two known biosynthetically related compounds, luffariellolide (6) and furospinosulin B (7). The structures of these compounds were elucidated on the basis of their spectroscopic data, experimental and calculated electronic circular dichroism (ECD) analysis, as well as comparison of the NMR data with those of known analogs. These metabolites are the first γ-oxygenated butenolide sesterterpenes to be reported from this genus. These compounds were evaluated in antimicrobial, anti-inflammatory, and cytotoxic assays. Only compounds 1, 3, and 6 exhibited moderate cytotoxicity against DU145, SW1990, Huh7, and PANC-1 cancer cell lines with IC50 values in the range of 2.11–13.35 μM. Furthermore, compound 2, without cytotoxicity, exhibited significant inhibitory effects (inhibitory rate 77.5%) on nitric oxide production induced by lipopolysaccharide at 10 μM.

Graphical Abstract

1. Introduction

Sesterterpenoids, mainly found in marine organisms, are a rare class of terpene that are structurally diverse and have a wide spectrum of biological activities [1,2]. Marine sponges represent an abundant source of bioactive sesterterpenoids [3,4]. A literature survey revealed that only three sesterterpenoids and no γ-oxygenated butenolide sesterterpenes or related derivatives have been isolated from sponges of the genus Dactylospongia [5,6]. Aside from a few sesterterpenoids, sponges of the genus Dactylospongia, in particular D. elegans, have been widely investigated as a rich source of sesquiterpene quinones/quinols, sesquiterpene acids, sesterterpene lactones, macrolides, and steroids [7]. These metabolites showed a spectrum of bioactivities, such as cytotoxic [8], anti-inflammatory [9], antibacterial [10], and protein kinase inhibitory activities [11].
As part of the ongoing bioactive natural product discovery from the organic extract of a marine sponge D. elegans, one fraction showed different LC-DAD-MS profiles to those of previously reported sesquiterpene quinones/hydroquinones based upon LC-MS analysis [6]. Further chemical investigation of this fraction led to the isolation of γ-oxygenated butenolide sesterterpene derivatives, dactylospenes A–E (15), and two known compounds (67), shown in Figure 1. Herein, we report the details of the isolation, structure elucidation, and biological activity evaluation of these metabolites.

2. Results

Dactylospene A (1) was obtained as a light red oil, and its molecular formula was determined as C25H38O3 according to the HRESIMS peak at m/z 404.3166 [M + NH4]+, requiring seven degrees of unsaturation. The IR spectrum showed absorption bands for hydroxy (3342 cm−1) and ester carbonyl (1760 cm−1) groups. Comparison of the 1H and 13C NMR data of 1 (Table 1) with those of the known compound 7 showed that they shared a linear sesterterpene skeleton [12], which was further confirmed by the HMBC and COSY correlations shown in Figure 2. The observation of a downfield shift in the C-21, from δC 73.1 in 7 to δC 99.1 in 1, confirmed that the hydroxyl group connected at C-21. The relative configuration of the double bonds in 1 was inferred to be the same as compound 7 and further established by the NOESY experiments (Figure 3). Strong NOESY correlations of overlapped proton signals at δH 2.00 and δH 5.11 suggested that these three groups of double-bonds Δ6,7, Δ10,11, and Δ14,15 were all E-geometry. Furthermore, the absolute stereochemistry of C-21 can be determined by following the determination method of O,O-dimethyllingshuiolide A [13]. The characteristic positive Cotton effect at 253 nm in the CD spectrum of 1 was virtually identical to that of the simplified models (detailed in the Supplementary Information S1), (S)-5-hydroxy-4-methylfuran-2(5H)-one (4S-8) (Figure 4). Consequently, absolute configuration of 1 was unassigned as 21S.
Dactylospene B (2) was also purified as a light red oil and exhibited a pseudomolecular ion [M + NH4]+ peak in the positive HRESIMS at m/z 418.3308, consistent with the molecular formula C26H40O3, which was supported by the 1H and 13C NMR data. The molecular formula indicated seven degrees of unsaturation. The IR spectrum of 2 showed strong absorption at 3465 and 1766 cm−1, assignable to hydroxy and ester carbonyl functionalities, respectively. The 13C NMR and DEPT spectra (Table 2) of 2 revealed 26 carbon signals, including one carbonyl carbon (δC 170.3), three sp2 quaternary carbons (δC 168.6, 144.4, and 130.9), three sp2 methine carbons (δC 124.6, 117.9, and 116.9), one sp3 oxymethine (δC 103.9), one methoxy (δC 56.1), two sp3 quaternary carbons (δC 42.0 and 33.2), two methine carbons (δC 43.9 and 41.8), eight methylene carbons (δC 38.6, 30.8, 29.4, 28.7, 27.5, 22.4, 21.9, and 21.7), and five methyl carbons (δC 25.2, 23.5, 22.4, 17.2, and 15.9), which accounted for four degrees of unsaturation. The remaining three degrees of unsaturation were caused by the presence of three rings in the molecule.
Interpretation of the 2D NMR data, including COSY, HMQC, and HMBC spectra, led to the construction of the planar structure of 2. The COSY spectrum of 2 suggested the presence of four individual spin systems: C-1−C-2−C-3 (a), C-5−C-6−C-7−C-8−C-18 (b), C-11−C-12 (c), and C-20−C-21−C-22 (d), which were accomplished with the assistance of the HMBC experiment (Figure 1). HMBC correlations from H3-24 to C-22, C-23, and C-25, from H3-25 to C-22, C-23, and C-24, and from H2-22 to C-24 and C-25 determined the existence of dimethylallyl moiety (C20-C25). Moreover, HMBC correlations from H2-3 in fragment a, and H-5 and H2-6 in fragment b to the same carbon C-4, as well as HMBC correlations from H3-17 to C-3, C-4, and C-5, allowed the linkage of fragments a and b via C-4 and the assignment of the methyl group CH3-17 at C-4. The dimethylhomoallyl group was attached to C-4 based on the HMBC correlations from H2-20 to C-3, C-4, and C-5. Further HMBC correlations from H3-18 to C-9, and from H3-19 to C-8, C-9, and C-10, revealed the connectivity of C-8 and C-10 through C-9 and placed the methyl group H3-19 at C-9 as well. Another two groups of HMBC cross-peaks from H-1 to C-5 and C-9, from H2-2, H-5 and H-6b to C-10, supported the linkage of C-1 and C-5 via C-10. Moreover, a suite of resonances at δC 170.3 (C-15), 168.6 (C-13), 116.9 (CH-14), 103.9 (CH-16), and 56.1 (16-OCH3), could be assigned to an α,β-unsaturated-γ-methoxy-γ-lactone moiety, which was further supported by HMBC correlations from H-16 to C-13, C-14, and C-15, from H-14 to C-13, C-15, and C-16, and from 16-OCH3 to C-16. This moiety was further linked to C-9 through fragment C-11–C-13, based on the HMBC correlations from H-14 to C-12 and from H-11 to C-9, C-10, and C-13. Thus, the planar structure of 2 was determined as depicted.
A NOESY experiment was also performed to determine the relative configuration of 2. The NOESY cross-peaks of H-5/H-20a and H-5/H3-18 indicated the cofacial orientation of these protons and methyl group, whereas the NOESY correlations of H-8/H3-19 indicated that these protons were oriented in the other direction. Therefore, we established the relative stereochemistry of 2 as 4R*,5S*,8R*,9R*.
The molecular formula for dactylospene C (3) was also deduced as C26H40O3 by HRESIMS. Analysis of the 1D and 2D NMR data (Table 2) for 3 and 2 showed that they shared the same planar structure. The similar NOESY correlations of H-5/H-20a, H-5/H3-18, and H-8/H3-19 revealed the same relative configurations of 3 as those of 2 at C-4, C-5, C-8, and C-9. However, the different but not mirrored CD spectra (Figure 5) and specific rotation values ( [ α ] D 25 13.9 for 2, [ α ] D 25 56.2 for 3) of 2 and 3 indicated that these two compounds are a pair of diastereomers.
To establish the absolute configuration of 2 and 3, we compared the ECD spectra of 2 and 3 with calculated ECD spectra of simplified models, 4R-8 and 4R,5S,8R,9R-9 (Figure 4). The negative cotton effect around 250 nm in 2 clearly indicated that the absolute configuration at C-16 is R. Meanwhile, the positive cotton effect around 250 nm in 3 allowed us to conclude that the absolute configuration at C-16 in 3 is S. Then, we determined the absolute configuration of the decaline substructure. As described above, 2 and 3 are a pair of diastereomers, and the only difference is the absolute configuration at C-16. Therefore, 2 and 3 have the same absolute configuration in the decaline moiety. According to the calculated ECD spectra of 9, if the compound has 4R,5S,8R,9R configuration, it shows a positive cotton effect around 205 nm. In the experimental ECD spectra, the positive cotton effect around 205 nm in 3 is more emphasized than the negative cotton effect around 205 nm in 2. This indicated that the decaline moiety in 2 and 3 has positive cotton effect around 205 nm. Therefore, we clarified the absolute configuration at C-4, C-5, C-8, and C-9 in 2 and 3 to be 4R,5S,8R,9R.
Dactylospene D (4) was isolated as a yellow oil and assigned the molecular formula of C27H44O4, based on HRESIMS data for the [M + NH4]+ ion at m/z 450.3581, which is consistent with six degrees of unsaturation. The 1H and 13C NMR signal patterns (Table 3) suggested the same structure core as compounds 2 and 3 with a α,β-unsaturated-γ-methoxy-γ-lactone moiety linked to the epi-halimane-type diterpenoid. Key HMBC and COSY correlations shown in Figure 2 confirmed this proposed structure. Through analysis of the remaining signals in the 13C NMR, two methyls (δC 24.9 and 25.0), three sp3 methylenes (δC 41.1, 39.8, and 17.8), one methoxy (δC 49.1), and one sp3 oxygenated quaternary carbon (δC 74.6) were deduced. The attachment at C-4 was a 2-methoxy-2-methylpentane unit, instead of the dimethylhomoallyl moiety in 2 and 3, supported by the COSY correlations of H-20a/H-21a and H-21b/H2-22, in addition to the HMBC correlations from H-20a to C-3, from H3-24 and H3-25 to C-22 and C-23, and from 23-OCH3 to C-23. Moreover, NOESY correlations of H-5/H-20a, H-5/H3-18, and H-8/H3-19 revealed the relative configurations of 4, which were the same as compounds 2 and 3. Finally, the similarity of their CD spectra between 2 and 4 suggested that compound 4 shared the same absolute configurations as those of 2 (Figure 5).
Dactylospene E (5) was also obtained as a light yellow oil. The molecular formula of C27H44O4 was deduced from its HRESIMS data (m/z 450.3578 [M + NH4]+). Compound 5 showed nearly the same chemical shifts as those of compound 4. Correlations from the 2D NMR spectra confirmed the same planar structure between 5 and 4 and the same configuration of epi-halimane core in 5 and 4. A comparison with CD spectra and specific rotation values obtained for 5 and 3 unambiguously assigned absolute configuration as 4R,5S,8R,9R,16R.
In addition to the five new compounds 15, two known compounds, identified as luffariellolide (6) and furospinosulin B (7), were also isolated as metabolites of D. elegans. These compounds were identified by comparing their spectral data with the spectroscopic data reported in the corresponding literature [12,14]. Moreover, the C-25 stereocenter in the γ-oxygenated butenolide unit could be assigned as an S configuration by comparison the specific rotation data of 6 ( [ α ] D 25 − 35.3, MeCN, c 1.0) with that of 1. Compounds 4 and 5 could possibly be formed by reaction with MeOH from compounds 2 and 3 during the isolation. However, when compounds 2 and 3 were stirred with silica and ODS in MeOH for 48 h, neither 4 nor 5 were detected by HPLC-UV analysis.
All the isolated compounds were tested for antimicrobial activity against two strains of hospital-acquired, methicillin-resistant Staphylococcus aureus (MRSA H0556 and MRSAH0117) and cytotoxic activity against DU145, SW1990, Huh7, and PANC-1 cancer cell lines. Unfortunately, the compounds tested exhibited no activity against the above strains. Only compounds 1, 3, and 6 exhibited moderate cytotoxicity against the above four cancer cell lines, with IC50 values in the range of 2.11–13.35 μM, while the other isolates were inactive (IC50 values > 50 μM) (Table 4). Moreover, compounds 15 were subjected to an evaluation of their anti-inflammatory activity. Compound 2 exhibited significantly greater inhibitory effects than 3 (inhibitory rate 77.5% for 2 and 30.4% for 3) on nitric oxide (NO) production induced by lipopolysaccharide (LPS) treatment of RAW 264.7 cells at 10 μM. In addition, the proliferation rate of RAW 264.7 cells was 151.2% with the treatment of 2 at 10 μM, which indicated that the anti-inflammatory effect of 2 was not achieved by its cytotoxicity. The biological evaluation indicated that R-γ-methoxy butenolide moiety positively affected the activity.

3. Experimental Section

3.1. General Experimental Procedures

UV, IR (KBr), and CD spectra were obtained on UV-8000 spectrophotometer (Shanghai Metash instruments Co., Shanghai, China), Jasco FTIR-400 spectrometer (Jasco Inc., Tokyo, Japan), and Jasco J-715 spectropolarimeter (Jasco Inc., Tokyo, Japan) in MeCN, respectively. Optical rotations were recorded on a Perkin-Elmer model 341 polarimeter (Perkin-Elmer Inc., Waltham, MA, USA). 1D NMR and 2D NMR spectra were acquired at room temperature (rt) using Bruker AMX-400 and Bruker Avance III DRX-600 instruments (Bruker Biospin Corp., Billerica, MA, USA) with TMS as the internal standard. HRESIMS data were obtained with the positive ion mode on an Agilent 6210 LC/MSD TOF mass spectrometer (Agilent Technologies Inc. Lake Forest, CA, USA). Reversed-phase HPLC was performed on a YMC-Pack Pro C18 RS (5 μm) column (YMC Co. Ltd., Kyoto, Japan) using the Waters 1525 separation module (Waters Corp., Milford, MA, USA) with a Waters 2998 photodiode array (PDA) detector (Waters Corp., Milford, MA, USA). Silica gel (200–300 mesh, Qingdao Ocean Chemical Co., Qingdao, China), Sephadex LH-20 (18–110 μm, Pharmacia Co., Piscataway, NJ, USA), and ODS (50 μm, YMC Co. Ltd., Kyoto, Japan) were used for column chromatography.

3.2. Animal Material

The marine sponge was collected off Yongxing Island in the South China Sea in March 2018 and identified as D. elegans by Professor Hou-Wen Lin. The sample of D. elegans (YC-3-2018) is deposited at the Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Second Military Medical University.

3.3. Fermentation, Extraction, and Isolation

The air-dried sponge (0.3 kg, dry weight) was powdered and extracted by 95% aqueous EtOH at rt. The combined extracts were concentrated under vacuum to give the crude extract (9.3 g), which was subjected to vacuum liquid chromatography on silica gel by gradient elution using CH2Cl2/MeOH (100:0 to 0:100, v:v) as solvents to give seven fractions (A–G). Fraction D (1.16 g) was further separated on an ODS (50 μm) column by stepwise gradient elution with MeOH/H2O (1:4, 2:3, 3:2, 4:1, 1:0) to afford 11 subfractions (D1–D11), and then subfractions D10 was subjected to column chromatography (CC) on Sephadex LH-20 with CH2Cl2/MeOH (1:1) as the eluting solvent to afford three subfractions (D10a–D10c). Subfraction D10b was purified by CC on Silica gel with n-hexane/acetone (15:1) as the eluting solvent to afford 2 (1.8 mg), 3 (1.6 mg), and subfraction D10b4, which was further purified by reversed-phase HPLC, eluting with 90% MeCN (2.0 mL/min), detected at 254 nm, to give 4 (tR = 23.3 min, 1.4 mg) and 5 (tR = 24.1 min, 1.6 mg). Fraction E (1.02 g) was further separated on an ODS (50 μm) column followed by stepwise gradient elution with MeOH/H2O (3:2, 4:1, 1:0) to afford ten subfractions (E1–E10), and then subfractions E7 and E9 were both purified by reversed-phase HPLC, eluting with 70% MeCN (2.0 mL/min), detected at 220 nm, to give 6 (1.2 mg, tR = 13.3 min), 1 (13.1 mg, tR = 15.2 min), and 7 (tR = 20.5 min, 1.7 mg).
Dactylospene A (1): light red oil; [ α ] D 25 − 12.5 (c 0.13, MeOH); UV (MeOH) (log ε) λmax 220 (4.29), 334 (2.13); IR (KBr) νmax 3342, 2962, 2923, 2855, 2729, 1760, 1649, 1603, 1535, 1447, 1381, 1335, 1267, 1180, 1133, 1027, 952, 889, 805, 739, 599 cm−1; CD (MeCN) (∆ε) 216 (−0.3), 253 (+0.2); 1H and 13C NMR data, see Table 1; HRESIMS m/z 404.3166 [M + NH4]+ (calcd for C25H42NO3, 404.3159).
Dactylospene B (2): light red oil; [ α ] D 25 + 13.9 (c 0.20, MeOH); UV (MeOH) (log ε) λmax 201 (4.47), 258 (4.02); IR (KBr) νmax 3465,2959, 2925, 2858, 1795, 1766, 1652, 1454, 1375, 1309, 1120, 959, 897, 860 cm−1; CD (MeCN) (∆ε) 202 (+4.1), 216 (+8.9), 254 (−3.8); 1H and 13C NMR data, see Table 2; HRESIMS m/z 418.3308 [M + NH4]+ (calcd for C26H44NO3, 418.3316).
Dactylospene C (3): light red oil; [ α ] D 25 + 56.2 (c 0.27, MeOH); UV (MeOH) (log ε) λmax 213 (4.64, 257 (4.36); IR (KBr) νmax 3466, 2959, 2926, 2858, 1795, 1765, 1651, 1454, 1376, 1310, 1203, 1119, 955, 897, 863, 804, 736, 647 cm−1; CD (MeCN) (∆ε) 201 (+31.6), 221 (+4.2), 245 (+20.1); 1H and 13C NMR data, see Table 2; HRESIMS m/z 418.3314 [M + NH4]+ (calcd for C26H44NO3, 418.3316).
Dactylospene E (4): light yellow oil; [ α ] D 25 + 2.3 (c 0.12, MeOH); UV (MeOH) (log ε) λmax 198 (4.36); IR (KBr) νmax 3360, 2960, 2924, 2853, 1795, 1766, 1738, 1462, 1374, 1261, 1093, 1021, 800, 700 cm–1; CD (MeCN) (∆ε) 206 (+2.5), 217 (+5.9), 251 (−3.9); 1H and 13C NMR data, see Table 3; HRESIMS m/z 450.3581 [M + NH4]+ (calcd for C27H48NO4, 450.3578).
Dactylospene D (5): light yellow oil; [ α ] D 25 + 111.7 (c 0.10, MeOH); UV (MeOH) (log ε) λmax 206 (4.58); IR (KBr) νmax 2926, 2860, 1795, 1767, 1650, 1460, 1373, 1309, 1260, 1202, 1118, 955, 896, 861, 804, 735 cm−1; CD (MeCN) (∆ε) 200 (+43.1), 223 (+0.3), 246 (+11.2); 1H and 13C NMR data, see Table 3; HRESIMS m/z 450.3595 [M + NH4]+ (calcd for C27H48NO4, 450.3578).

3.4. ECD Calculations

Conformational searches for simplified models 8 and 9 were carried out via Macromodel 9.9.223 software (Schrödinger, LLC, Portland, OR, USA) using Merck Molecular Force Field (MMFF) applying a 21 kJ/mol energy window. Subsequently, the conformers with a Boltzmann population of over 1% were re-optimized at the B3LYP/6-31G(d) level with Gaussian 09 by employing the polarizable continuum model (PCM) in MeCN, which generated two conformers for model 8 and four conformers for model 9. The theoretical calculations of ECD for simplified models 8 and 9 were calculated at the CAM-B3LYP/TZVP (PCM/MeCN) level. The ECD spectra were generated by the program SpecDis 1.6 applying a Gaussian band shape with the width of 0.35 eV, from dipole-length rotational strengths [15].

3.5. Biological Assays

The antimicrobial activities of compounds 17 against two strains of hospital-acquired, methicillin-resistant Staphylococcus aureus (MRSA H0556 and MRSAH0117) were evaluated according to Clinical and Laboratory Standards Institute (CLSI) guidelines [16,17], and chloromycetin was used as the positive control (MIC90 2 μg/mL), while methicillin was used as the negative control (MIC90 128 μg/mL). The cytotoxic activity of compounds 17 against DU145, SW1990, Huh7, and PANC-1 cell lines was performed by the Cell Counting Kit-8 (CCK-8) assay, as described before [18]. Each cancer cell line was treated with the indicated test compound at various concentrations, in triplicate, and cisplatin was used as a positive control. The anti-inflammatory assay of compounds 15 was measured using the Griess reagent following the reported method [19]. The cell viability assay of compounds 15 were evaluated by the CCK-8 assay, as above.

4. Conclusions

Investigation on the secondary metabolites from the marine sponge, D. elegans, led to the isolation and structure elucidation of a series of γ-hydroxybutenolide sesterterpene derivatives, dactylospenes A–E (15), together with two known biosynthetically related compounds 67. From a biosynthetic perspective, compounds 25 may be generated from the possible precursor 1 by cyclization and methoxy-substitution reactions. These compounds were evaluated in antibacterial and cytotoxic activities. Only compounds 1, 4, and 6 exhibited moderate cytotoxicity against DU145, SW1990, Huh7, and PANC-1 cancer cell lines with IC50 values ranging from 2.11 to 13.35 μm. Compound 2 exhibited potent anti-inflammatory activity by inhibiting the production of NO in RAW264.7 cells activated by lipopolysaccharide, with an inhibitory rate of 77.5%. Interestingly, the anti-inflammatory activity of compound 2 was not achieved through cytotoxic activity, indicating that compound 2 deserves further study for its therapeutic potential to develop new anti-inflammatory drugs.

Supplementary Materials

The following are available online at https://www.mdpi.com/1660-3397/18/10/491/s1, 1D and 2D NMR, UV, IR, and HRESMS data of 15.

Author Contributions

The contributions of the respective authors are listed as follows: H.-B.Y. drafted the work. H.-B.Y. and B.-B.G. performed the collection, extraction, isolation, and structure elucidation. B.-B.G. and A.I. finished the ECD calculation. W.-L.J. performed the cytotoxicity evaluation. S.-P.W. and A.E. contributed to checking and confirming all of the procedures of the isolation and the structure elucidation. F.Y. and H.-W.L. designed the study, supervised the laboratory work, and contributed to the critical reading and revision of the manuscript. All the authors have read the final manuscript and approved the submission. All authors have read and agreed to the published version of the manuscript.

Funding

The research was funded by the National Key Research and Development Program of China (No. 2018YFC0310900), the National Natural Science Foundation of China (Nos. U1605221, 41576130, 81602982, 41606173 and 81703624), the Natural Science Foundation of Shanghai (No. 20ZR1470600), the Shanghai Rising-Star Program (19QA1405300), the Shanghai Municipal Health Commission Excellent Young Talent Program (No. 2018YQ28), and the Oceanic Interdisciplinary Program of Shanghai Jiao Tong University (SL2020MS029).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Huang, A.C.; Kautsar, S.A.; Hong, Y.J.; Medema, M.H.; Bond, A.D.; Tantillo, D.J.; Osbourn, A. Unearthing a sesterterpene biosynthetic repertoire in the Brassicaceae through genome mining reveals convergent evolution. Proc. Natl. Acad. Sci. USA 2017, 114, E6005–E6014. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Máximo, P.; Lourenço, A. Marine Sesterterpenes: An Overview. Curr. Org. Chem. 2018, 22, 2381–2393. [Google Scholar] [CrossRef]
  3. Khushi, S.; Nahar, L.; Salim, A.A.; Capon, R.J. Cacolides: Sesterterpene Butenolides from a Southern Australian Marine Sponge, Cacospongia sp. Mar. Drugs 2018, 16, 456. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Ebada, S.S.; Lin, W.; Proksch, P. Bioactive sesterterpenes and triterpenes from marine sponges: Occurrence and pharmacological significance. Mar. Drugs 2010, 8, 313–346. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Wang, J.; Jiao, W.H.; Huang, J.; Wang, J.H.; Lin, H.W. Advances in studies on chemical constituents in marine sponges of genus Dactylospongia and their bioactivities. Chin. J. Mar. Drugs 2016, 35, 103–110. [Google Scholar]
  6. Yu, H.-B.; Yin, Z.-F.; Gu, B.-B.; Zhang, J.-P.; Wang, S.-P.; Yang, F.; Lin, H.-W. Cytotoxic meroterpenoids from the marine sponge Dactylospongia elegans. Nat. Prod. Res. 2019. [Google Scholar] [CrossRef] [PubMed]
  7. Yu, H.-B.; Gu, B.-B.; Wang, S.-P.; Cheng, C.-W.; Yang, F.; Lin, H.-W. New diterpenoids from the marine sponge Dactylospongia elegans. Tetrahedron 2017, 73, 6657–6661. [Google Scholar] [CrossRef]
  8. Li, J.; Wang, Z.; Yang, F.; Jiao, W.H.; Lin, H.W.; Xu, S.H. Two new steroids with cytotoxicity from the marine sponge Dactylospongia elegans collected from the South China Sea. Nat. Prod. Res. 2018, 33, 1340–1344. [Google Scholar] [CrossRef] [PubMed]
  9. Li, J.; Yang, F.; Wang, Z.; Wu, W.; Liu, L.; Wang, S.P.; Zhao, B.X.; Jiao, W.H.; Xu, S.H.; Lin, H.W. Unusual anti-inflammatory meroterpenoids from the marine sponge Dactylospongia sp. Org. Biomol. Chem. 2018, 16, 6773–6782. [Google Scholar] [CrossRef] [PubMed]
  10. Hagiwara, K.; Garcia Hernandez, J.E.; Harper, M.K.; Carroll, A.; Motti, C.A.; Awaya, J.; Nguyen, H.-Y.; Wright, A.D. Puupehenol, a Potent Antioxidant Antimicrobial Meroterpenoid from a Hawaiian Deep-Water Dactylospongia sp. Sponge. J. Nat. Prod. 2015, 78, 325–329. [Google Scholar] [CrossRef] [PubMed]
  11. Daletos, G.; de Voogd, N.J.; Mueller, W.E.G.; Wray, V.; Lin, W.; Feger, D.; Kubbutat, M.; Aly, A.H.; Proksch, P. Cytotoxic and Protein Kinase Inhibiting Nakijiquinones and Nakijiquinols from the Sponge Dactylospongia metachromia. J. Nat. Prod. 2014, 77, 218–226. [Google Scholar] [CrossRef] [PubMed]
  12. Fattorusso, E.; Lanzotti, V.; Magno, S.; Mayol, L.; Rosa, M.D.; Ialenti, A. Linear sesterterpenes from the Caribbean sponge Thorecta horridus with inflammatory activity. Bioorg. Med. Chem. Lett. 1991, 1, 639–644. [Google Scholar] [CrossRef]
  13. Torii, M.; Kato, H.; Hitora, Y.; Angkouw, E.D.; Mangindaan, R.E.P.; de Voogd, N.J.; Tsukamoto, S. Lamellodysidines A and B, Sesquiterpenes Isolated from the Marine Sponge Lamellodysidea herbacea. J. Nat. Prod. 2017, 80, 2536–2541. [Google Scholar] [CrossRef] [PubMed]
  14. Albizati, K.F.; Holman, T.; Faulkner, D.J.; Glaser, K.B.; Jacobs, R.S. Luffariellolide, an Anti-inflammatory Sesterterpene from the Marine Sponge Luffariella sp. Experientia 1987, 43, 949–950. [Google Scholar] [CrossRef]
  15. Li, J.; Gu, B.-B.; Sun, F.; Xu, J.-R.; Jiao, W.-H.; Yu, H.-B.; Han, B.-N.; Yang, F.; Zhang, X.-C.; Lin, H.-W. Sesquiterpene Quinones/Hydroquinones from the Marine Sponge Spongia pertusa Esper. J. Nat. Prod. 2017, 80, 1436–1445. [Google Scholar] [CrossRef] [PubMed]
  16. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast. In Approved Standard, 3rd ed.; Document M27-A3; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2009. [Google Scholar]
  17. Jiao, W.-H.; Li, J.; Liu, Q.; Xu, T.-T.; Shi, G.-H.; Yu, H.-B.; Yang, F.; Han, B.-N.; Li, M.; Lin, H.-W. Dysidinoid A, an unusual meroterpenoid with anti-MRSA activity from the South China Sea sponge Dysidea sp. Molecules 2014, 19, 18025–18032. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Yu, H.-B.; Wang, X.-L.; Zhang, Y.-X.; Xu, W.-H.; Zhang, J.-P.; Zhou, X.-Y.; Lu, X.-L.; Liu, X.-Y.; Jiao, B.-H. Libertellenones O–S and Eutypellenones A and B, Pimarane Diterpene Derivatives from the Arctic Fungus Eutypella sp. D-1. J. Nat. Prod. 2018, 81, 1553–1560. [Google Scholar] [CrossRef] [PubMed]
  19. Chen, S.; Deng, Y.; Yan, C.; Wu, Z.; Guo, H.; Liu, L.; Liu, H. Secondary Metabolites with Nitric Oxide Inhibition from Marine-Derived Fungus Alternaria sp. 5102. Mar. Drugs 2020, 18, 426. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chemical structures of compounds 17.
Figure 1. Chemical structures of compounds 17.
Marinedrugs 18 00491 g001
Figure 2. COSY and key HMBC correlations for compounds 15.
Figure 2. COSY and key HMBC correlations for compounds 15.
Marinedrugs 18 00491 g002
Figure 3. Selected NOESY correlations for compounds 15.
Figure 3. Selected NOESY correlations for compounds 15.
Marinedrugs 18 00491 g003
Figure 4. Calculated electronic circular dichroism (ECD) spectra of the simplified models 8 (a) and 9 (b).
Figure 4. Calculated electronic circular dichroism (ECD) spectra of the simplified models 8 (a) and 9 (b).
Marinedrugs 18 00491 g004
Figure 5. Experimental CD spectrum (MeCN) of 25.
Figure 5. Experimental CD spectrum (MeCN) of 25.
Marinedrugs 18 00491 g005
Table 1. 1H (400 MHz) and 13C NMR (100 MHz) spectroscopic data of 1.
Table 1. 1H (400 MHz) and 13C NMR (100 MHz) spectroscopic data of 1.
PositionδCδH, Mult. (J in Hz)PositionδCδH, Mult. (J in Hz)
1171.6, C 14124.2, CH5.11, q (6.4) c
2117.6, CH5.85, s15135.0, C
3169.5, C 1639.6, CH2 a2.00, m c
427.8, CH22.46, brd (30.8)1726.5, CH2 b2.06, m c
525.2, CH22.32, m18123.9, CH5.11, q (6.4) c
6121.9, CH5.11, q (6.4) c19131.3, C
7137.4, C 2025.7, CH31.60, s c
839.7, CH2 a2.00, m c2199.1, CH6.00, s
926.8, CH2 b2.06, m c2217.7, CH31.63, s c
10124.4, CH5.11, q (6.4) c2316.0, CH31.60, s c
11135.3, C 2416.3, CH31.60, s c
1239.7, CH2 a2.00, m c2516.2, CH31.68, s c
1326.6, CH2 b2.06, m c
a,b Values with identical superscript within each column may be interchanged; c Values with identical superscript within each column are mutually overlapped.
Table 2. 1H (600 MHz) and 13C NMR (150 MHz) spectroscopic data of 2 and 3.
Table 2. 1H (600 MHz) and 13C NMR (150 MHz) spectroscopic data of 2 and 3.
Position23
δCδH, Mult. (J in Hz)δCδH, Mult. (J in Hz)
1117.9, CH 5.43, dd (4.2, 2.4)118.4, CH 5.43, dd (4.2, 2.4)
222.4, CH22.03, m22.9, CH22.03, m
3a28.7, CH21.23, m28.5, CH21.23, m
3b 1.41, m 1.41, m
433.2, C 33.9, C
541.8, CH1.59, m42.5, CH1.59, m
6a29.4, CH21.13, m29.9, CH21.13, m
6b 1.82, m 1.82, m
7a30.8, CH21.44, m31.3, CH21.44, m
7b 1.61, m 1.61, m
843.9, CH1.34, m44.4, CH1.34, m
942.0, C 43.1, C
10144.4, C 145.0, C
11a27.5, CH21.35, m28.2, CH21.35, m
11b 1.91, m 1.91, m
12a21.7, CH22.00, m22.3, CH22.00, m
12b 2.18, m 2.18, m
13168.6, C 169.1, C
14116.9, CH5.86, s117.5, CH5.86, s
15170.3, C 170.8, C
16103.9, CH5.56, s104.4, CH5.61, s
16-OCH356.1, CH33.53, s56.5, CH33.50, s
1723.5, CH30.86, s23.9, CH30.84, s
1815.9, CH30.88, d (7.2)16.4, CH30.84, d (6.6)
1922.4, CH31.06, s23.0, CH31.04, s
20a38.6, CH21.12, m39.1, CH21.02, m
20b 1.33, m 1.39, m
2121.9, CH21.86, m22.4, CH21.90, m
22124.6, CH5.01, t (7.2)125.2, CH5.04, t (7.2)
23130.9, C 130.9, C
2417.2, CH31.58, s17.6, CH31.59, s
2525.2, CH31.68, s25.7, CH31.66, s
Table 3. 1H (600 MHz) and 13C NMR (150 MHz) spectroscopic data of 4 and 5.
Table 3. 1H (600 MHz) and 13C NMR (150 MHz) spectroscopic data of 4 and 5.
Position45
δCδH, Mult. (J in Hz)δCδH, Mult. (J in Hz)
1118.0, CH5.44, t (3.6)118.5, CH 5.41, t (3.6)
222.4, CH21.99, m23.0, CH21.98, m
3a28.6, CH21.27, m28.6, CH21.27, m
3b 1.38, m 1.38, m
433.4, C 34.0, C
542.3, CH1.55, m43.4, CH1.53, m
6a29.3, CH21.13, m29.9, CH21.11, m
6b 1.83, m 1.81, m
7a30.8, CH21.44, m31.3, CH21.42, m
7b 1.60, m 1.59, m
843.9, CH1.37, m44.4, CH1.36, m
941.9, C 42.5, C
10144.4, C 145.1, C
11a27.6, CH21.33, m28.1, CH21.32, m
11b 1.93, m 1.91, m
12a21.9, CH21.95, m22.5, CH22.01, m
12b 2.17, m 2.11, m
13168.5, C 169.0, C
14117.0, CH5.87, s117.5, CH5.85, s
15170.2, C 170.8, C
16103.9, CH5.65, s104.5, CH5.61, s
16-OCH356.0, CH33.55, s56.8, CH33.54, s
1723.5, CH30.85, s24.0, CH30.83, s
1815.8, CH30.88, d (7.2)16.4, CH30.87, d (7.2)
1922.5, CH31.06, s23.0, CH31.04, s
20a39.2, CH21.02, m39.8, CH20.95, m
20b 1.34, m 1.33, m
2117.2, CH21.23, m17.8, CH21.23, m
1.31, m 1.29, m
2241.2, CH21.36, m41.1, CH21.35, m
2373.9, C 74.6, C
2424.1, CH31.12, s24.9, CH31.11, s
2524.6, CH31.13, s25.0, CH31.12, s
23-OCH348.6, CH33.16, s49.1, CH33.16, s
Table 4. Cytotoxic activities of compounds 17 (IC50 in μM).
Table 4. Cytotoxic activities of compounds 17 (IC50 in μM).
CompoundDU145SW1990Huh7PANC-1
12.87 ± 0.632.11 ± 0.212.87 ± 0.237.59 ± 0.62
2>50>50>50>50
313.35 ± 1.417.40 ± 0.592.37 ± 0.23>50
4>50>50>50>50
5>50>50>50>50
63.21 ± 0.223.55 ± 0.313.61 ± 0.175.21 ± 0.55
7>50>50>50>50
Cisplatin2.90 ± 0.395.09 ± 0.181.11 ± 0.114.59 ± 0.13

Share and Cite

MDPI and ACS Style

Yu, H.-B.; Gu, B.-B.; Iwasaki, A.; Jiang, W.-L.; Ecker, A.; Wang, S.-P.; Yang, F.; Lin, H.-W. Dactylospenes A–E, Sesterterpenes from the Marine Sponge Dactylospongia elegans. Mar. Drugs 2020, 18, 491. https://doi.org/10.3390/md18100491

AMA Style

Yu H-B, Gu B-B, Iwasaki A, Jiang W-L, Ecker A, Wang S-P, Yang F, Lin H-W. Dactylospenes A–E, Sesterterpenes from the Marine Sponge Dactylospongia elegans. Marine Drugs. 2020; 18(10):491. https://doi.org/10.3390/md18100491

Chicago/Turabian Style

Yu, Hao-Bing, Bin-Bin Gu, Arihiro Iwasaki, Wen-Li Jiang, Andrew Ecker, Shu-Ping Wang, Fan Yang, and Hou-Wen Lin. 2020. "Dactylospenes A–E, Sesterterpenes from the Marine Sponge Dactylospongia elegans" Marine Drugs 18, no. 10: 491. https://doi.org/10.3390/md18100491

APA Style

Yu, H. -B., Gu, B. -B., Iwasaki, A., Jiang, W. -L., Ecker, A., Wang, S. -P., Yang, F., & Lin, H. -W. (2020). Dactylospenes A–E, Sesterterpenes from the Marine Sponge Dactylospongia elegans. Marine Drugs, 18(10), 491. https://doi.org/10.3390/md18100491

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop